Extrait

• To demonstrate treatment efficacy of bosentan as add-on therapy in progressive pulmonary sarcoidosis in comparison to placebo, as measured by a composite clinical score based on pulmonary function test, cardiopulmonary exercise testing, HRCT and dyspnoea level.

Critère d'inclusion

• Progressive pulmonary sarcoidosis

Liens

• euctr
• ictrp